The Metabolic Effects of Myoinositol and Metforn1in In Polycystic Ovarian Syndrolne

Abstract

Ob;ective: In PCOS patients, the mean BMI was compared between Myo-inositol and Metformin. \~ ethodology: This quasi-experimental study was conducted at Department of Gynaecology and Obstetrics, KRL Hospital, Islamabad from May 24.2017 to Nov 24,2017. To choose a volunteer for the study, non-probability sequential sampling was utilized. There were two groups of participants: one group got myoinositol1 gm twice a day, and the other group received 250 mg metformin pill thrice a day for the duration of the experiment. After three months of medication treatment, the patients were contacted for a follow-up, and all of their baseline measures were retaken. Comparisons between baseline and post-treatment BMI were made. Post-segmentation, the t-test, and the chi-square test were used. P-value 0.05 was deemed significant. Results: The research comprised a total of 152 patients. Patients were an average of 27.4 years old, with a standard deviation of 7.6. Significantly better efficacy of my-inositol in terms of BMI (t= -9.89, P=O.OOO, C.I=95% ) than Metformin in polycystic ovary syndrome patients was found. Condusion: Mycrinositol was more effective than Metformin at reducing BMI consistently in polycystic ovary syndrome.